Pricing
  1. JP-listed companies
  2. COSMO BIO COMPANY, LIMITED
  3. Financials
  4. Depreciation & amortization

COSMO BIO COMPANY, LIMITED【JP:3386】

Market cap
¥7.9B
P/E ratio
33.8x
Cosmo Bio imports and sells life science research reagents and equipment to researchers at universities and corporations, offering over 10 million products from 500 companies worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDepreciation & amortization (Million JPY)YoY (%)
Dec 31, 2025167+22.79%
Dec 31, 2024136-8.11%
Dec 31, 2023148+4.96%
Dec 31, 2022141-15.06%
Dec 31, 2021166-5.14%
Dec 31, 2020175-15.46%
Dec 31, 2019207+16.29%
Dec 31, 2018178+14.10%
Dec 31, 2017156+83.53%
Dec 31, 201685+7.59%
Dec 31, 201579-4.82%
Dec 31, 201483

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)